Celsus Therapeutics Plc


Celsus Therapeutics is a drug development company focusing on novel anti-inflammatory, first-in-class synthetic drugs termed Multi-Functional Anti-Inflammatory Drugs (MFAIDs). Celsus’s proprietary drug technology platform is unique and potentially offers an answer to an urgent unmet need: the lack of satisfactory alternatives to corticosteroids in the treatment of a multitude of inflammatory diseases. The company has assembled an experienced team that shares its vision and is committed to making it a success.

HQ Address: 

53 Davies Street, Mayfair
London W1K 5JH
United Kingdom

HQ Country: 
United Kingdom
HQ State: 
Greater London
HQ City: 
+44 (0)20 3322 1321